HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (32) Citing Articles via Google Scholar Google Scholar Articles by Medina, D. Search for Related Content PubMed PubMed Citation Articles by Medina, D.

Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA

(Requests for offprints should be addressed to D Medina; dmedina{at}bcm.tmc.edu)

The ovarian hormones, estrogen and progesterone, play a pivotal role in normal and neoplastic development of the mammary gland. These hormones have a paradoxical role as long duration of estrogen and progesterone are associated with increased breast cancer risk, while short duration of pregnancy level doses are associated with a reduced breast cancer risk. The protective effects of estrogen and progesterone, as well as pregnancy, have been extensively studied in animal models. Recent studies have demonstrated that these hormones induce alterations in gene expression in the mammary epithelial cells which persist for a long time after the hormones are withdrawn from the host. It is postulated that hormones induce a switch in mammary developmental fate which decreases the risk of breast cancer over the lifetime of the host. Some of the possible cellular pathways persistently altered by short term hormone exposure are a decrease in growth factors and an increase in apoptosis. The expression of these genes, in turn, may be affected by alterations in genes regulating chromatin remodeling. The relative contributions of host-mediated factors and mammary cell intrinsic factors remain to be determined. The current studies have moved this research area from the biological to the molecular realm and offer the potential for directing prevention efforts at specific molecular targets.

This article has been cited by other articles:

				A. Lukanova, R. Andersson, M. Wulff, A. Zeleniuch-Jacquotte, K. Grankvist, L. Dossus, Y. Afanasyeva, R. Johansson, A. A. Arslan, P. Lenner, et al. Human Chorionic Gonadotropin and Alpha-Fetoprotein Concentrations in Pregnancy and Maternal Risk of Breast Cancer: A Nested Case-Control Study Am. J. Epidemiol., December 1, 2008; 168(11): 1284 - 1291. [Abstract] [Full Text] [PDF]

				S. Y. Lee, M. L. Palmer, P. J. Maniak, S. H. Jang, P. D. Ryu, and S. M. O'Grady P2Y receptor regulation of sodium transport in human mammary epithelial cells Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1472 - C1480. [Abstract] [Full Text] [PDF]

				Y. Ning, B. Hoang, A. G. P. Schuller, T. P. Cominski, M.-S. Hsu, T. L. Wood, and J. E. Pintar Delayed Mammary Gland Involution in Mice with Mutation of the Insulin-Like Growth Factor Binding Protein 5 Gene Endocrinology, May 1, 2007; 148(5): 2138 - 2147. [Abstract] [Full Text] [PDF]

				L. C. Hartmann, T. R. Milanese, C. M. Vachon, and R. A. Vierkant Response: Re: Age-Related Lobular Involution and Risk of Breast Cancer J Natl Cancer Inst, April 4, 2007; 99(7): 572 - 572. [Full Text] [PDF]

				G. Ferretti, A. Felici, and F. Cognetti Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 634 - 634. [Full Text] [PDF]

				D. Zhou, J. j. Ye, Y. Li, K. Lui, and S. Chen The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha Nucleic Acids Res., November 6, 2006; 34(20): 5974 - 5986. [Abstract] [Full Text] [PDF]

				L. Hilakivi-Clarke, A. Shajahan, B. Yu, and S. de Assis Differentiation of Mammary Gland as a Mechanism to Reduce Breast Cancer Risk J. Nutr., October 1, 2006; 136(10): 2697S - 2699S. [Full Text] [PDF]

				R. Aneja, J. Zhou, B. Zhou, R. Chandra, and H. C. Joshi Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice. Mol. Cancer Ther., September 1, 2006; 5(9): 2366 - 2377. [Abstract] [Full Text] [PDF]

				C. Manhes, C. Kayser, P. Bertheau, B. Kelder, J. J Kopchick, P. A Kelly, P. Touraine, and V. Goffin Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma. J. Endocrinol., August 1, 2006; 190(2): 271 - 285. [Abstract] [Full Text] [PDF]